CME: CME Group Inc. Financials
CME Group Inc. Income Statement
Total revenue
Net income
Gross margin TTM
86.09%
Operating margin TTM
64.86%
Net profit margin TTM
62.02%
Return on investment TTM
14.08%
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 6,520,600,000 | 6,130,100,000 | 5,578,900,000 | 5,019,400,000 |
| Operating income | 4,229,500,000 | 3,931,500,000 | 3,435,700,000 | 3,015,900,000 |
| Net income | 4,044,400,000 | 3,525,800,000 | 3,226,200,000 | 2,691,000,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total revenue | 6,520,600,000 | 6,130,100,000 | 5,578,900,000 | 5,019,400,000 |
| Cost of revenue | 907,000,000 | 850,300,000 | 828,600,000 | 753,100,000 |
| Gross profit | 5,613,600,000 | 5,279,800,000 | 4,750,300,000 | 4,266,300,000 |
| Research and development expenses | 0 | 0 | 0 | 0 |
| General and administrative expenses | 150,500,000 | 132,700,000 | 144,400,000 | 137,400,000 |
| Selling and marketing expenses | 0 | 0 | 0 | 0 |
| Selling, general and administrative expenses | 150,500,000 | 132,700,000 | 144,400,000 | 137,400,000 |
| Other expenses | 1,233,600,000 | 1,215,600,000 | 1,170,200,000 | 1,113,000,000 |
| Operating expenses | 1,384,100,000 | 1,348,300,000 | 1,314,600,000 | 1,250,400,000 |
| Cost and expenses | 2,291,100,000 | 2,198,600,000 | 2,143,200,000 | 2,003,500,000 |
| Net interest income | -129,700,000 | -160,900,000 | -159,400,000 | -162,700,000 |
| Interest income | 0 | 0 | 0 | 0 |
| Interest expense | 129,700,000 | 160,900,000 | 159,400,000 | 162,700,000 |
| Depreciation and amortization | 275,000,000 | 336,800,000 | 352,600,000 | 362,600,000 |
| EBITDA | 5,720,300,000 | 5,039,100,000 | 4,665,600,000 | 4,015,600,000 |
| EBIT | 5,445,300,000 | 4,702,300,000 | 4,313,000,000 | 3,653,000,000 |
| Non-operating income (excl. interest) | -1,215,700,000 | -770,800,000 | -877,300,000 | -637,100,000 |
| Operating income | 4,229,500,000 | 3,931,500,000 | 3,435,700,000 | 3,015,900,000 |
| Total other income/expenses (net) | 1,101,000,000 | 609,900,000 | 717,900,000 | 474,400,000 |
| Income before tax | 5,330,500,000 | 4,541,400,000 | 4,153,600,000 | 3,490,300,000 |
| Income tax expense | 1,273,200,000 | 1,015,600,000 | 927,400,000 | 799,300,000 |
| Net income from continuing operations | 4,057,300,000 | 3,525,800,000 | 3,226,200,000 | 2,691,000,000 |
| Net income from discontinued operations | 0 | 0 | 0 | 0 |
| Other adjustments to net income | 0 | 0 | 0 | 0 |
| Net income | 4,044,400,000 | 3,525,800,000 | 3,226,200,000 | 2,691,000,000 |
| Net income deductions | -5,700,000 | 0 | 0 | 0 |
| Bottom line net income | 4,021,000,000 | 3,481,500,000 | 3,185,600,000 | 2,657,200,000 |
| EPS | 11 | 10 | 9 | 7 |
| Diluted EPS | 11 | 10 | 9 | 7 |
| Weighted average shares outstanding | 359,633,000 | 359,389,000 | 359,023,000 | 358,713,000 |
| Weighted average diluted shares outstanding | 360,233,000 | 359,944,000 | 359,500,000 | 359,181,000 |
CME Group Inc. Balance Sheet
Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
3,422,300,000%
Total debt / assets MRQ
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Total assets | 198,548,400,000 | 137,447,000,000 | 129,706,100,000 | 174,175,700,000 |
| Total liabilities | 169,820,200,000 | 110,960,100,000 | 102,968,200,000 | 147,297,000,000 |
| Total equity | 28,728,200,000 | 26,486,900,000 | 26,737,900,000 | 26,878,700,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash and cash equivalents | 4,423,400,000 | 2,892,400,000 | 2,912,000,000 | 2,720,100,000 |
| Short-term investments | 125,000,000 | 113,200,000 | 111,700,000 | 96,000,000 |
| Cash and short-term investments | 4,548,400,000 | 3,005,600,000 | 3,023,700,000 | 2,816,100,000 |
| Net receivables | 639,200,000 | 573,100,000 | 535,600,000 | 483,200,000 |
| Accounts receivable | 639,200,000 | 573,100,000 | 535,600,000 | 483,200,000 |
| Other receivables | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 |
| Prepaid expenses | 0 | 0 | 0 | 0 |
| Other current assets | 0 | 99,454,800,000 | 91,330,900,000 | 135,779,000,000 |
| Total current assets | 5,187,600,000 | 103,033,500,000 | 94,890,200,000 | 139,078,300,000 |
| Property, plant and equipment (net) | 573,000,000 | 386,200,000 | 409,500,000 | 455,500,000 |
| Goodwill | 10,514,700,000 | 10,486,900,000 | 10,495,300,000 | 10,482,500,000 |
| Intangible assets | 19,786,000,000 | 19,996,900,000 | 20,225,500,000 | 20,445,000,000 |
| Goodwill and intangible assets | 30,300,700,000 | 30,483,800,000 | 30,720,800,000 | 30,927,500,000 |
| Long-term investments | 1,500,500,000 | 0 | 0 | 0 |
| Tax assets | 124,200,000 | 0 | 0 | 0 |
| Other non-current assets | 160,862,400,000 | 3,543,500,000 | 3,685,600,000 | 3,714,400,000 |
| Total non-current assets | 193,360,800,000 | 34,413,500,000 | 34,815,900,000 | 35,097,400,000 |
| Other assets | 0 | 0 | 0 | 0 |
| Total assets | 198,548,400,000 | 137,447,000,000 | 129,706,100,000 | 174,175,700,000 |
| Total payables | 71,800,000 | 79,900,000 | 90,600,000 | 121,400,000 |
| Accounts payable | 71,800,000 | 79,900,000 | 90,600,000 | 121,400,000 |
| Other payables | 0 | 0 | 0 | 0 |
| Accrued expenses | 0 | 0 | 0 | 0 |
| Short-term debt | 55,800,000 | 749,800,000 | 0 | 16,000,000 |
| Capital lease obligations (current) | 0 | 0 | 0 | 0 |
| Tax payables | 0 | 0 | 0 | 0 |
| Deferred revenue | 0 | 0 | 0 | 0 |
| Other current liabilities | -71,800,000 | 101,484,200,000 | 93,326,300,000 | 137,550,100,000 |
| Total current liabilities | 55,800,000 | 102,313,900,000 | 93,416,900,000 | 137,687,500,000 |
| Long-term debt | 3,422,300,000 | 2,678,200,000 | 3,425,400,000 | 3,422,400,000 |
| Capital lease obligations (non-current) | 279,100,000 | 0 | 0 | 0 |
| Deferred revenue (non-current) | 0 | 0 | 0 | 0 |
| Deferred tax liabilities (non-current) | 5,366,400,000 | 5,246,800,000 | 5,327,700,000 | 5,361,100,000 |
| Other non-current liabilities | 160,696,600,000 | 721,200,000 | 798,200,000 | 826,000,000 |
| Total non-current liabilities | 169,764,400,000 | 8,646,200,000 | 9,551,300,000 | 9,609,500,000 |
| Other liabilities | 0 | 0 | 0 | 0 |
| Capital lease obligations | 279,100,000 | 0 | 0 | 0 |
| Total liabilities | 169,820,200,000 | 110,960,100,000 | 102,968,200,000 | 147,297,000,000 |
| Treasury stock | 0 | 0 | 0 | 0 |
| Preferred stock | 0 | 0 | 0 | 0 |
| Common stock | 3,600,000 | 3,600,000 | 3,600,000 | 3,600,000 |
| Retained earnings | 6,433,200,000 | 4,185,800,000 | 4,455,200,000 | 4,746,800,000 |
| Additional paid-in capital | 22,209,500,000 | 22,403,000,000 | 22,334,700,000 | 22,261,600,000 |
| Accumulated other comprehensive income/loss | 81,900,000 | -105,500,000 | -55,600,000 | -133,300,000 |
| Other stockholders' equity | 0 | 0 | 0 | 0 |
| Total stockholders' equity | 28,728,200,000 | 26,486,900,000 | 26,737,900,000 | 26,878,700,000 |
| Total equity | 28,728,200,000 | 26,486,900,000 | 26,737,900,000 | 26,878,700,000 |
| Minority interest | 0 | 0 | 0 | 0 |
| Total liabilities and total equity | 198,548,400,000 | 137,447,000,000 | 129,706,100,000 | 174,175,700,000 |
| Total investments | 1,625,500,000 | 113,200,000 | 111,700,000 | 96,000,000 |
| Total debt | 3,757,200,000 | 3,428,000,000 | 3,425,400,000 | 3,438,400,000 |
| Net debt | -666,200,000 | 535,600,000 | 513,400,000 | 718,300,000 |
CME Group Inc. Cash Flow Statement
Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
| Period end | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Cash from operations | 4,277,100,000 | 3,690,500,000 | 3,453,800,000 | 3,056,000,000 |
| Cash from investing | 1,498,800,000 | -82,600,000 | 20,900,000 | -489,800,000 |
| Cash from financing | 56,509,500,000 | 5,076,500,000 | -48,339,300,000 | -25,381,700,000 |
| Net change in cash | 62,285,400,000 | 8,684,400,000 | -44,864,600,000 | -22,815,500,000 |
All line items
| Line item | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Net income | 4,072,200,000 | 3,525,800,000 | 3,226,200,000 | 2,691,000,000 |
| Depreciation and amortization | 330,900,000 | 336,800,000 | 352,600,000 | 362,600,000 |
| Deferred income tax | -6,100,000 | -66,400,000 | -75,000,000 | -23,200,000 |
| Stock-based compensation | 94,800,000 | 89,500,000 | 82,900,000 | 84,300,000 |
| Change in working capital | 99,700,000 | -191,600,000 | -95,200,000 | -95,200,000 |
| Accounts receivable | -67,100,000 | -39,400,000 | -51,500,000 | -51,100,000 |
| Inventory | 0 | 0 | 0 | 0 |
| Accounts payable | -8,100,000 | -10,700,000 | -30,800,000 | 72,500,000 |
| Other working capital | 174,900,000 | -141,500,000 | -12,900,000 | -116,600,000 |
| Other non-cash items | -314,400,000 | -3,600,000 | -37,700,000 | 36,500,000 |
| Net cash from operating activities | 4,277,100,000 | 3,690,500,000 | 3,453,800,000 | 3,056,000,000 |
| Investments in property, plant and equipment | -83,500,000 | -94,000,000 | -76,400,000 | -89,700,000 |
| Acquisitions (net) | 1,580,400,000 | 9,900,000 | 95,500,000 | -402,000,000 |
| Purchases of investments | -6,000,000 | -4,500,000 | -4,100,000 | -4,400,000 |
| Sales/maturities of investments | 7,900,000 | 6,000,000 | 5,900,000 | 6,300,000 |
| Other investing activities | 0 | 0 | 0 | 0 |
| Net cash from investing activities | 1,498,800,000 | -82,600,000 | 20,900,000 | -489,800,000 |
| Net debt issuance | -9,400,000 | 0 | -16,400,000 | -15,200,000 |
| Long-term net debt issuance | -9,400,000 | 0 | -16,400,000 | -15,200,000 |
| Short-term net debt issuance | 0 | 0 | 0 | 0 |
| Net stock issuance | -266,100,000 | -33,000,000 | -21,400,000 | -24,800,000 |
| Net common stock issuance | -266,100,000 | -33,000,000 | -21,400,000 | -24,800,000 |
| Common stock issuance | 0 | 0 | 0 | 0 |
| Common stock repurchased | -266,100,000 | -33,000,000 | -21,400,000 | -24,800,000 |
| Net preferred stock issuance | 0 | 0 | 0 | 0 |
| Net dividends paid | -3,933,000,000 | -3,584,200,000 | -3,235,500,000 | -2,633,500,000 |
| Common dividends paid | -3,933,000,000 | -3,584,200,000 | -3,235,500,000 | -2,633,500,000 |
| Preferred dividends paid | 0 | 0 | 0 | 0 |
| Other financing activities | 60,718,000,000 | 8,693,700,000 | -45,066,000,000 | -22,708,200,000 |
| Net cash from financing activities | 56,509,500,000 | 5,076,500,000 | -48,339,300,000 | -25,381,700,000 |
| Effect of FX changes on cash | 0 | 0 | 0 | 0 |
| Net change in cash | 62,285,400,000 | 8,684,400,000 | -44,864,600,000 | -22,815,500,000 |
| Cash at end of period | 164,079,500,000 | 101,794,100,000 | 93,109,700,000 | 137,974,300,000 |
| Cash at beginning of period | 101,794,100,000 | 93,109,700,000 | 137,974,300,000 | 160,789,800,000 |
| Operating cash flow | 4,277,100,000 | 3,690,500,000 | 3,453,800,000 | 3,056,000,000 |
| Capital expenditure | -83,500,000 | -94,000,000 | -76,400,000 | -89,700,000 |
| Free cash flow | 4,193,600,000 | 3,596,500,000 | 3,377,400,000 | 2,966,300,000 |
| Income taxes paid | 1,164,000,000 | 1,197,600,000 | 1,109,400,000 | 973,400,000 |
| Interest paid | 135,600,000 | 129,900,000 | 129,900,000 | 133,200,000 |